Charming Medical Statistics
Total Valuation
MCTA has a market cap or net worth of $504.26 million. The enterprise value is $502.48 million.
| Market Cap | 504.26M |
| Enterprise Value | 502.48M |
Important Dates
The last earnings date was Thursday, July 30, 2026, after market close.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MCTA has 17.18 million shares outstanding. The number of shares has increased by 5.29% in one year.
| Current Share Class | 15.18M |
| Shares Outstanding | 17.18M |
| Shares Change (YoY) | +5.29% |
| Shares Change (QoQ) | +10.59% |
| Owned by Insiders (%) | 71.90% |
| Owned by Institutions (%) | 0.30% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 104.89 |
| Forward PS | n/a |
| PB Ratio | 97.33 |
| P/TBV Ratio | 97.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 104.51 |
| EV / EBITDA | 2,689.39 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.89 |
| Quick Ratio | 1.82 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 4.86 |
| Debt / FCF | n/a |
| Interest Coverage | -1.85 |
Financial Efficiency
Return on equity (ROE) is -0.87% and return on invested capital (ROIC) is 1.86%.
| Return on Equity (ROE) | -0.87% |
| Return on Assets (ROA) | 0.89% |
| Return on Invested Capital (ROIC) | 1.86% |
| Return on Capital Employed (ROCE) | -0.53% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $165,783 |
| Profits Per Employee | -$781 |
| Employee Count | 29 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 6.68 |
Taxes
In the past 12 months, MCTA has paid $156,114 in taxes.
| Income Tax | 156,114 |
| Effective Tax Rate | 116.97% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 81.33 |
| Average Volume (20 Days) | 874,470 |
Short Selling Information
The latest short interest is 575,764, so 3.35% of the outstanding shares have been sold short.
| Short Interest | 575,764 |
| Short Previous Month | 575,764 |
| Short % of Shares Out | 3.35% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MCTA had revenue of $4.81 million and -$22,648 in losses. Loss per share was -$0.00.
| Revenue | 4.81M |
| Gross Profit | 4.63M |
| Operating Income | 108,509 |
| Pretax Income | 133,466 |
| Net Income | -22,648 |
| EBITDA | 186,837 |
| EBIT | -29,237 |
| Loss Per Share | -$0.00 |
Balance Sheet
The company has $7.68 million in cash and $908,016 in debt, with a net cash position of $6.77 million or $0.39 per share.
| Cash & Cash Equivalents | 7.68M |
| Total Debt | 908,016 |
| Net Cash | 6.77M |
| Net Cash Per Share | $0.39 |
| Equity (Book Value) | 5.18M |
| Book Value Per Share | 0.30 |
| Working Capital | 3.84M |
Cash Flow
In the last 12 months, operating cash flow was -$1.22 million and capital expenditures -$339,560, giving a free cash flow of -$1.56 million.
| Operating Cash Flow | -1.22M |
| Capital Expenditures | -339,560 |
| Depreciation & Amortization | 216,074 |
| Net Borrowing | -445,784 |
| Free Cash Flow | -1.56M |
| FCF Per Share | -$0.09 |
Margins
Gross margin is 96.36%, with operating and profit margins of 2.26% and -0.47%.
| Gross Margin | 96.36% |
| Operating Margin | 2.26% |
| Pretax Margin | 2.78% |
| Profit Margin | -0.47% |
| EBITDA Margin | 3.89% |
| EBIT Margin | -0.61% |
| FCF Margin | n/a |
Dividends & Yields
MCTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.29% |
| Shareholder Yield | -5.29% |
| Earnings Yield | -0.00% |
| FCF Yield | -0.31% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MCTA has an Altman Z-Score of 40.59 and a Piotroski F-Score of 2.
| Altman Z-Score | 40.59 |
| Piotroski F-Score | 2 |